Table 7.
The changed proportion of immune cell types in the two groups during supplementation period
| Variables | Groups (number) | Δ8th week | Δ20th week | Δ36th week | Δ44th week | ΔE-12th week | ΔE-24th week |
|---|---|---|---|---|---|---|---|
| CD3CD4 (%) | control (n = 7) | –1.6 ± 16.56 | –6.67 ± 10.69 | - | - | - | - |
| fucoidan (n = 13) | –6.14 ± 12.06 | –2.83 ± 9.45 | –51 ± 2.78 | –16.5 ± 3.53 | –81 ± 1.31 | –16.5 ± 4.95 | |
| CD3CD8 (%) | control (n = 7) | 4.8 ± 7.19 | 1.67 ± 4.72 | - | - | - | - |
| fucoidan (n = 13) | –1.571 ± 4.97 | –4.83 ± 6.85 | 1.5 ± 2.12 | –6.5 ± 0.7 | –3.5 ± 3.53 | –1.5 ± 0.7 | |
| CD4CD25 (%) | control (n = 7) | –2 ± 0.44 | 0 ± 1 | - | - | - | - |
| fucoidan (n = 13) | –0.14 ± 0.37 | 0 ± 0.63 | –0.5 ± 0.7 | 0 ± 0 | 0 ± 0 | 0 ± 0 | |
| CD4CD45RA (%) | control (n = 7) | –10 ± 16.21 | –4.33 ± 25.16 | - | - | - | - |
| fucoidan (n = 13) | 1.83 ± 10.55 | 0.6 ± 20.14 | - | - | - | - | |
| CD4CD45RO (%) | control (n = 7) | –0.8 ± 1.92 | –0.33 ± 2.3 | - | - | - | - |
| fucoidan (n = 13) | 0.83 ± 1.72 | 0.4 ± 1.67 | - | - | - | - | |
| CD19 (%) | control (n = 7) | –3.8 ± 7.66 | 4.67 ± 15.14 | - | - | - | - |
| fucoidan (n = 13) | 0.57 ± 6.26 | 4.17 ± 6.01 | 3 ± 11.31 | 9.5 ± 6.36 | 4 ± 2.82 | 0 ± 5.65 |
∆: The changed concentrations of cytokines (supplementation week – 0 week).